MCM
ITCI
Moore Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 661 |
|
|
2025
Q1 | – | Sell |
-40,000
| Closed | -$3.34M | – | 584 |
|
|
2024
Q4 | $3.34M | Buy |
+40,000
| New | +$3.34M | 0.04% | 206 |
|
|
2024
Q3 | – | Sell |
-25,000
| Closed | -$1.71M | – | 526 |
|
|
2024
Q2 | $1.71M | Hold |
25,000
| – | – | 0.03% | 249 |
|
|
2024
Q1 | $1.73M | Hold |
25,000
| – | – | 0.03% | 226 |
|
|
2023
Q4 | $1.79M | Buy |
+25,000
| New | +$1.79M | 0.03% | 203 |
|
|
2022
Q4 | – | Sell |
-180,185
| Closed | -$8.38M | – | 643 |
|
|
2022
Q3 | $8.38M | Sell |
180,185
-6,121
| -3% | -$285K | 0.2% | 85 |
|
|
2022
Q2 | $10.6M | Buy |
186,306
+107,638
| +137% | +$6.14M | 0.28% | 56 |
|
|
2022
Q1 | $4.81M | Sell |
78,668
-1,632
| -2% | -$99.9K | 0.12% | 200 |
|
|
2021
Q4 | $4.2M | Buy |
+80,300
| New | +$4.2M | 0.08% | 246 |
|
|
2016
Q1 | – | Sell |
-45,000
| Closed | -$2.42M | – | 332 |
|
|
2015
Q4 | $2.42M | Buy |
+45,000
| New | +$2.42M | 0.08% | 172 |
|